Bradley A. Krasnick
- Oncology top 5%
- Lung Cancer Research Studies 16
- Pancreatic and Hepatic Oncology Research 16
- Vascular Tumors and Angiosarcomas 5
- Neurology top 10%
- Neuroblastoma Research and Treatments 13
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 20
-
- Sarcoma Diagnosis and Treatment 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Ryan C. FieldsGeorge A. PoultsidesKamran IdreesWilliam G. HawkinsShishir K. MaithelAlexandra G. Lopez‐AguiarS. Peter GoedegebuureSharon M. Weber
- Cited by
- OncologyNeurologyEpidemiology
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Bradley A. Krasnick
45 papers receiving 730 citations
Peers
Comparison fields: 5 of 75
- Oncology 500
- Neurology 143
- Epidemiology 261
- Immunology 133
- Pulmonary and Respiratory Medicine 150
Countries citing papers authored by Bradley A. Krasnick
This map shows the geographic impact of Bradley A. Krasnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley A. Krasnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley A. Krasnick more than expected).
Fields of papers citing papers by Bradley A. Krasnick
This network shows the impact of papers produced by Bradley A. Krasnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley A. Krasnick. The network helps show where Bradley A. Krasnick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bradley A. Krasnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 44 | |
| 3 | 2021 | 34 | |
| 4 | 2020 | 19 | |
| 5 | 2020 | 4 | |
| 6 | 2020 | 11 | |
| 7 | 2019 | 20 | |
| 8 | 2019 | 3 | |
| 9 | 2019 | 28 | |
| 10 | 2019 | 5 | |
| 11 | 2018 | 18 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 17 | |
| 14 | 2018 | 34 | |
| 15 | 2018 | 16 | |
| 16 | 2018 | 37 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 21 | |
| 19 | 2017 | 4 | |
| 20 | 2016 | 36 |
About Bradley A. Krasnick
Bradley A. Krasnick is a scholar working on Oncology, Neurology and Epidemiology, having authored 46 papers that have together received 733 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (20 papers), Lung Cancer Research Studies (16 papers), Pancreatic and Hepatic Oncology Research (16 papers), Neuroblastoma Research and Treatments (13 papers), Sarcoma Diagnosis and Treatment (6 papers), Vascular Tumors and Angiosarcomas (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Oncology (500 citations), Neurology (143 citations) and Epidemiology (261 citations). Bradley A. Krasnick has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Ryan C. Fields, George A. Poultsides, Kamran Idrees, William G. Hawkins, Shishir K. Maithel, Alexandra G. Lopez‐Aguiar, S. Peter Goedegebuure, Sharon M. Weber, Paula Marincola Smith and Flavio G. Rocha. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.